{"name":"Michael Pulsipher","slug":"michael-pulsipher","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE42MUtmdFN3cHNCWU1HQi1nVnFTNzNBY0NxbzF2Mjc3bjVSYTJKckxRd3oyZjFFQ21sQnNsME95bkdHNmt2aXlkWjNXUG1iZjczUm1vQmp1YUNEVzFhY19B?oc=5","date":"2024-04-18","type":"regulatory","source":"Nature","summary":"Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients","headline":"Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxNYThhY1ZIN2F0blhZR2pRX1RIZi10VGxzTW1zTjBXdGdSWVFMbFM0REJFZFBfWmU3aEZ0UkJ6ams4d2x2eHo0VW1xejNBZ2ZNU2dzZFJDdjNZenRXLWlXaUxNNUlhWjBNaVlaeDFNckg2ZzcybTg0cGo0N0l6bWNvR2JfVTJEOTJISUppZUxLd2JmbDRna3d3c1Q5ZXloUmN0eWVMSnh3SGZUUFhKR2pzdVZTa1NrSVVFMWFNZWl1dG1uLXBMYklLVmZTUE1DMUFNQmRqQzRoeTlrTDA?oc=5","date":"2021-12-01","type":"pipeline","source":"University of Utah Health","summary":"Sequencing of Bone Marrow DNA May Predict Leukemia Relapse After CAR-T Therapy | Huntsman Cancer Institute - University of Utah Health","headline":"Sequencing of Bone Marrow DNA May Predict Leukemia Relapse After CAR-T Therapy | Huntsman Cancer Institute","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}